{
    "eid": "2-s2.0-85037616835",
    "title": "Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia",
    "cover-date": "2017-12-01",
    "subject-areas": [
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [],
    "authors": [
        "Jae Yong Kwak"
    ],
    "citedby-count": 58,
    "ref-count": 29,
    "ref-list": [
        "Science",
        "A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining",
        "An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity",
        "European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013",
        "Chronic Myeloid Leukemia",
        "Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)",
        "Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: Implications for early intervention strategies",
        "Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib",
        "Final 5-year study results of DASISION: The dasatinib versus imatinib study in treatment-Na\u00efve chronic myeloid leukemia patients trial",
        "Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial",
        "Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors",
        "Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1",
        "Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia",
        "Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia",
        "Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase",
        "Optimization of radotinib doses for the treatment of Asian patients with chronic myelogenous leukemia based on dose-response relationship analyses",
        "Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase",
        "Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia",
        "Effects of lower dose of imatinib to CML patients",
        "Chronic myeloid leukemia in Asia",
        "Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia",
        "Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia",
        "Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina",
        "Blood",
        "Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: A subanalysis of the IRIS study",
        "Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia",
        "Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase",
        "J Clin Oncol",
        "Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib"
    ],
    "affiliation": [
        {
            "affiliation-city": "Jongno-gu",
            "affilname": "Kangbuk Samsung Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Suwon",
            "affilname": "The Catholic University of Korea, St. Vincent's Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "The Catholic University of Korea Seoul St. Mary's Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Korea University Guro Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Busan",
            "affilname": "Pusan National University Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Ewha Womans University Mokdong Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Ulsan",
            "affilname": "Ulsan University Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Suwon",
            "affilname": "Ajou University Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seongnam",
            "affilname": "Gachon University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ramathibodi Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Wonju",
            "affilname": "Wonju Severance Christian Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Daegu",
            "affilname": "Keimyung University, Dongsan Medical Center",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Inje University Paik Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Quezon City",
            "affilname": "St. Luke's Medical Center Quezon City",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Central Jakarta",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chuncheon",
            "affilname": "Hallym University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Jeonju",
            "affilname": "Jeonbuk National University, School of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Suwon",
            "affilname": "SKKU School of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Busan",
            "affilname": "Dong-A University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Gwangju",
            "affilname": "Chonnam National University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "University of Ulsan College of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Batangas",
            "affilname": "Mary Mediatrix Medical Center",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "Bristol-Myers Squibb",
        "Pfizer",
        "Novartis",
        "Roche",
        "Ariad Pharmaceuticals"
    ]
}